U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07199699) titled 'Subxiphoid VATS for Giant Mediastinal Teratoma' on Aug. 24.
Brief Summary: For giant mediastinal teratomas, the only treatment option available is usually open-chest surgery, which causes significant trauma, leads to obvious postoperative pain and may result in long-term complications such as chest wall deformity. Currently, we have developed a new treatment method. We use a double retractor system to pull the upper and lower ends of the sternum, lifting it to obtain sufficient surgical space behind the sternum. This enables us to perform minimally invasive tumor resection through the subxiphoid approach with thoracoscopy. The advant...